Zoetis (ZTS) Construction in Progress (2012 - 2025)
Zoetis' (ZTS) quarterly Construction in Progress came in at $1.3 billion in Q4 2025, down 4.29% year-on-year from $1.4 billion in Q4 2024, and down 4.29% on a QoQ basis from $1.4 billion in Q4 2024.
Zoetis (ZTS) Construction in Progress (2012 - 2025) Analysis & Trends
Zoetis (ZTS) has 14 years of Construction in Progress data on file, last reported at $1.3 billion in Q4 2025.
- On a quarterly basis, Construction in Progress fell 4.29% year-over-year to $1.3 billion in Q4 2025; TTM through Dec 2025 was $1.3 billion, a 4.29% decrease from a year earlier, with the FY2025 full-year figure at $1.3 billion, down 4.29% from the prior year.
- Construction in Progress for Q4 2025 stood at $1.3 billion, down from $1.4 billion in the prior quarter.
- Over the last five years, Construction in Progress for ZTS reached as high as $1.4 billion in Q4 2024 and fell as low as $742.0 million in Q4 2021.
- Historically, Construction in Progress has averaged $1.1 billion across 5 years, with a median of $1.1 billion in 2023.
- Across the five-year window, Construction in Progress surged 33.29% in 2023 and dropped 4.29% in 2025, its largest moves.
- Year by year, Construction in Progress stood at $742.0 million in 2021, then grew by 9.7% to $814.0 million in 2022, then jumped by 33.29% to $1.1 billion in 2023, then rose by 24.7% to $1.4 billion in 2024, then declined by 4.29% to $1.3 billion in 2025.
- Per Business Quant data, the three most recent Construction in Progress figures were $1.3 billion in Q4 2025, $1.4 billion in Q4 2024, and $1.1 billion in Q4 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Construction in Progress (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Vireo Growth | 10.57 Bn | 10.41 Bn | 59.30 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.30 Bn |
| Dec 31, 2024 | 1.35 Bn |
| Dec 31, 2023 | 1.09 Bn |
| Dec 31, 2022 | 814.00 Mn |
| Dec 31, 2021 | 742.00 Mn |
| Dec 31, 2020 | 673.00 Mn |
| Dec 31, 2019 | 553.00 Mn |
| Dec 31, 2018 | 454.00 Mn |
| Dec 31, 2017 | 254.00 Mn |
| Dec 31, 2016 | 212.00 Mn |
| Dec 31, 2015 | 185.00 Mn |
| Dec 31, 2014 | 167.00 Mn |
| Dec 31, 2013 | 199.00 Mn |
| Dec 31, 2012 | 159.00 Mn |